However, this effect isn't directly through GCG receptor but through another protein called FGF21, which is secreted by the liver
Suspected cancer: recognition and referral
And so when employees realize youre not going to cover that, they will find other alternatives and places to get [GLP-1 agonists] which are a 1/4 of the cost or less. -Human Resource Representative, large manufacturer A GLP-1 agonist has recently been approved for additional diagnoses such as certain cardiovascular risks and liver diseases, which will further increase the number of eligible individuals
Retatrutide also showed significant improvements from baseline across cardiovascular risk factors, such as waist circumference, non-HDL cholesterol, triglycerides, systolic blood pressure and high-sensitivity C-reactive protein
10.1016/j.bbrc.2007.08.196 Biochem